TAQNYET ADDAWA STORY
Taqnyet Addawa Pharma is a well-established since 2009, Its focusing to provide the Saudi Arabian Market pharmaceuticals products. Taqnyet Addawa has Keened to chose a partners with global reputation for high quality and Variety products conforming to international standards practices with competitive prices its provide customers excellent services such quick delivery, advanced logistic and distribution system . In 2021 the company turned into a British-Saudi mixed company in order to expanding; it increased products portfolio and now it is moving to manufacture medicine and spreading in MENA region. Taqnyet Addawa Pharma is Covering all areas in KSA with supply chain e-store and Distributors network.
To be a key partner for business stakeholders by providing comprehensive solutions in the healthy sector at different geographies areas.
To provide continually renewable solutions in the areas of health & medicines in MENA territory.
Our strategic plan is aligned with the Saudi Arabia 2030 vision, By investing in the pharmaceutical sector, we aim to contribute to the development of a knowledge-based economy and create job opportunities for Saudi market.
Our efforts will support the government's goals of promoting innovation, entrepreneurship, and the overall well-being of the MENA region.
State of art pharmaceutical factory : Our strategic plan includes the establishment of the state of art pharmaceutical factory. The Factory will be equipped with the latest technology and machinery to ensure the production of high-quality medicines. It will adhere to strict quality control measures and follow international standards; EUGMP, USGMP in manufacturing processes. The facility will not only meet the local demand for pharmaceuticals but also have the capacity to export products to other countries, contributing to the growth of the healthcare industry.
TA PHARMA HISTORY
START IN KSA
2009 Founded and Start up business with private sector for medical solution.
Start up business with governmental (MOH).
Strategic alliances with local and international manufacturers.
GOVERNMENTAL MARKET APPROACH
NUPCO & ETIMAD registration focusing on governmental direct purchase
LAUNCHING PHARMA PRODUCTS
DOX Pharma products.
Launching more generic products.
ENROLLED NEW BOARD
Turned into a Saudi-British mixed company in order to expand, Increase products portfolio, to move to manufacturing medicines, As Well as spreading in MENA region.
Strategic alliances with regional and international manufacturing of branded generic products and nutraceutical products.
STRATEGIC PLAN FOR MANUFACTURING SITE
Establishing our own manufacturing site in KSA and develop organization structure.
Revolutionize healthcare: Our commitment to research and development drives us to develop cutting-edge pharmaceutical solutions that address unmet medical needs. Experience the future of healthcare
Collaborate for success: We believe in the power of collaboration. Through strategic partnerships with local healthcare providers, academic institutions, and government agencies, we aim to drive innovation and improve patient access to life-changing treatments.
Sustainable and responsible practices: We care about the environment and the communities we serve. Through sustainable practices, charitable initiatives, and social responsibility efforts, we strive to make a positive impact.
Safety and compliance first: Your safety is our priority. We are committed to upholding strict regulatory compliance, adhering to quality standards, and following ethical guidelines.